The opioid growth factor, [Met5]-enkephalin, inhibits DNA synthesis during recornification of mouse tail skin

R P Wilson1, P J McLaughlin, C M Lang

  • 1Department of Comparative Medicine, College of Medicine, The Pennsylvania State University, Hershey 17033-2390, USA. rpw4@psu.edu

Cell Proliferation
|June 9, 2000
PubMed

Insights

Endogenous opioid peptides inhibit skin cell growth. Blocking opioid receptors or administering opioid peptides affects DNA synthesis in regenerating mouse tail skin, revealing a role in wound healing.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Cell Biology

Background:

  • Opioid peptides are known negative regulators of epithelial growth and regeneration.
  • The role of endogenous opioids in the specific context of stratum corneum renewal following injury remains to be fully elucidated.

Purpose of the Study:

  • To investigate the involvement of endogenous opioid peptides in the renewal of the stratum corneum after tape stripping injury in mouse tail skin.
  • To determine the effects of opioid receptor blockade and stimulation on basal cell DNA synthesis post-injury.

Main Methods:

  • Mice (C57BL/6 J) were subjected to tape stripping of tail skin to induce injury.
  • Systemic injections of opioid antagonist naltrexone (NTX) or opioid peptide [Met5]-enkephalin (OGF) were administered at various time points post-injury.
  • DNA synthesis was measured using radiolabeled thymidine incorporation.
  • Immunocytochemistry was used to detect OGF and its receptor (OGFr) in epidermal cells.

Main Results:

  • Naltrexone administration elevated basal cell DNA synthesis by 36-66% 24 hours after injury, indicating opioid-mediated inhibition.
  • [Met5]-enkephalin suppressed DNA synthesis by 37-46% at 24 hours post-wounding.
  • The effect of OGF on DNA synthesis was time-dependent, with maximal inhibition (72%) observed when administered 16 hours post-injury.
  • Naloxone blocked OGF-induced inhibition, confirming receptor-mediated effects.
  • OGF and OGFr were detected in basal and suprabasal epidermal layers of both injured and uninjured skin.

Conclusions:

  • A native opioid peptide and its receptor are present in mouse tail skin epidermis.
  • The endogenous opioid system functions to tonically inhibit the proliferative response to wounding in tail skin.
  • Disrupting opioid peptide-receptor interactions can enhance basal cell DNA synthesis, suggesting a therapeutic potential for wound healing.

Related Concept Videos